Neurocognitive impairment in obstructive sleep apnea

Chest

Volumn 141, Issue 6, 2012, Pages 1601-1610

  Lal, Chitra ^a   Strange, Charlie ^a   Bachman, David ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; NARCOTIC AGENT; OXYGEN; PSYCHOTROPIC AGENT;

AGE; ALCOHOL CONSUMPTION; ALLELE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BRAIN REGION; CIGARETTE SMOKING; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DOWN SYNDROME; EARLY DIAGNOSIS; EARLY INTERVENTION; ENDOCRINE DISEASE; ENDOTHELIAL DYSFUNCTION; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GRAY MATTER; HUMAN; HYPERTENSION; HYPOTHYROIDISM; HYPOXIA; INFLAMMATION; LEARNING DISORDER; MEDICAL RESEARCH; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PARIETAL LOBE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR VIGILANCE TASK; REVIEW; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; STEER CLEAR PERFORMANCE TEST; STROKE; STRUCTURAL NEUROIMAGING; TEST OF REPETITIVE FINGER TAPPING; WECHSLER INTELLIGENCE SCALE;

EID: 84862009397     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2214     Document Type: Article

References (81)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-1235. (Pubitemid 23115702)
2. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998;157(1):144-148. (Pubitemid 28071275)
3. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;163(3 pt 1):608-613. (Pubitemid 32230817)
4. Verstraeten E. Neurocognitive effects of obstructive sleep apnea syndrome. Curr Neurol Neurosci Rep. 2007;7(2) : 161-166. (Pubitemid 46416067)
5. Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117-129. (Pubitemid 40471632)
6. Rhodes SK, Shimoda KC, Waid LR, et al. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr. 1995;127(5):741-744.
7. Kelly DA, Claypoole KH, Coppel DB. Sleep apnea syndrome: symptomatology, associated features, and neurocognitive correlates. Neuropsychol Rev. 1990;1(4):323-342.
8. Kim SJ, Lee JH, Lee DY, et al. Neurocognitive dysfunction associated with sleep quality and sleep apnea in patients with mild cognitive impairment. Am J Geriatr Psychiatry.2011;19(4):374-381.
9. Owens JA. Neurocognitive and behavioral impact of sleep disordered breathing in children. Pediatr Pulmonol. 2009; 44(5):417-422.
10. Chervin RD, Archbold KH, Dillon JE, et al. Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics. 2002;109(3):449-456. (Pubitemid 34177508)
11. Brockmann PE, Urschitz MS, Schlaud M, Poets CF. Primary snoring in school children: prevalence and neurocognitive impairments. Sleep Breath. 2012;16(1):23-29.
12. Antonelli Incalzi R, Marra C, Salvigni BL, et al. Does cognitive dysfunction conform to a distinctive pattern in obstructive sleep apnea syndrome? J Sleep Res. 2004;13(1):79-86. (Pubitemid 38365725)
13. Mazza S, Pépin JL, Naëgelé B, Plante J, Deschaux C, Lévy P. Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests. Eur Respir J.2005;25(1):75-80. (Pubitemid 40207734)
14. Archbold KH, Borghesani PR, Mahurin RK, Kapur VK, Landis CA. Neural activation patterns during working memory tasks and OSA disease severity: preliminary findings. J Clin Sleep Med. 2009;5(1):21-27.
15. Bédard MA, Montplaisir J, Richer F, Rouleau I, Malo J. Obstruc tive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol. 1991;13(6) : 950-964.
16. Caselli RJ. Obstructive sleep apnea, apolipoprotein E e4, and mild cognitive impairment. Sleep Med. 2008;9(8):816-817.
17. Quan SF, Chan CS, Dement WC, et al. The association between obstructive sleep apnea and neurocognitive performance - the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2011;34(3):303-314B.
18. Petersen RC, Roberts RO, Knopman DS, et al The Mayo Clinic Study of Aging. Prevalence of mild cognitive impairment is higher in men. Neurology. 2010;75(10):889-897.
19. Ayalon L, Ancoli-Israel S, Drummond SP. Obstructive sleep apnea and age: a double insult to brain function? Am J Respir Crit Care Med. 2010;182(3):413-419.
20. Ovchinsky A, Rao M, Lotwin I, Goldstein NA. The familial aggregation of pediatric obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg. 2002;128(7):815-818. (Pubitemid 34755314)
21. Guindalini C, Colugnati FA, Pellegrino R, Santos-Silva R, Bittencourt LR, Tufik S. Influence of genetic ancestry on the risk of obstructive sleep apnoea syndrome. Eur Respir J.2010;36(4):834-841.
22. Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4) : 213-227.
23. Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA. 2001;285(22):2888-2890. (Pubitemid 32537353)
24. Spira AP, Blackwell T, Stone KL, et al. Sleep-disordered breath ing and cognition in older women. J Am Geriatr Soc.2008;56(1):45-50.
25. Gozal D, Capdevila OS, Kheirandish-Gozal L, Crabtree VM. APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology. 2007;69(3):243-249. (Pubitemid 47205685)
26. Trois MS, Capone GT, Lutz JA, et al. Obstructive sleep apnea in adults with Down syndrome. J Clin Sleep Med.2009;5(4):317-323.
27. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003;27(2):260-268. (Pubitemid 36255810)
28. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994;154(19):2219-2224. (Pubitemid 24317269)
29. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271- 2277. (Pubitemid 33135251)
30. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med. 2001;249(2):153-161. (Pubitemid 32202505)
31. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000;161(2 pt 1) : 375-380. (Pubitemid 30129441)
32. Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc. 1992;40(4):325-335.
33. Chan KK, Chiu KC, Chu LW. Association between alcohol consumption and cognitive impairment in Southern Chinese older adults. Int J Geriatr Psychiatry. 2010;25(12):1272-1279.
34. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8: 36.
35. Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest. 1992;102(6) : 1663-1667.
36. Clarnette RM, Patterson CJ. Hypothyroidism: does treatment cure dementia? J Geriatr Psychiatry Neurol. 1994;7(1):23-27. (Pubitemid 24028152)
37. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA.1995;274(23):1846-1851. (Pubitemid 26001260)
38. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):49-55. (Pubitemid 30224785)
39. Panza F, Frisardi V, Capurso C, et al. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis. 2010;21(3) : 691-724.
40. Wright CB, Elkind MS, Luo X, Paik MC, Sacco RL. Reported alcohol consumption and cognitive decline: The northern Manhattan study. Neuroepidemiology. 2006;27(4):201-207. (Pubitemid 46005739)
41. Feige B, Gann H, Brueck R, et al. Effects of alcohol on polysomnographically recorded sleep in healthy subjects. Alcohol Clin Exp Res. 2006;30(9):1527-1537. (Pubitemid 44272742)
42. Issa FG, Sullivan CE. Upper airway closing pressures in snorers. J Appl Physiol. 1984;57(2):528-535. (Pubitemid 14033151)
43. Palomäki H. Snoring and the risk of ischemic brain infarction. Stroke. 1991;22(8):1021-1025.
44. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182(2):269-277.
45. Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;175(6):612-617. (Pubitemid 46438946)
46. Tatemichi TK, Foulkes MA, Mohr JP, et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke. 1990;21(6):858-866. (Pubitemid 20209711)
47. Desmond DW, Moroney JT, Paik MC, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 2000;54(5):1124-1131. (Pubitemid 30151857)
48. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15-28. (Pubitemid 29358484)
49. Shirani A, Paradiso S, Dyken ME. The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. Sleep Med. 2011;12(6):591-597.
50. Beebe DW, Groesz L, Wells C, Nichols A, McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep.2003;26(3):298-307. (Pubitemid 39610677)
51. Naismith S, Winter V, Gotsopoulos H, Hickie I, Cistulli P. Neurobehavioral functioning in obstructive sleep apnea: differential effects of sleep quality, hypoxemia and subjective sleepiness. J Clin Exp Neuropsychol. 2004;26(1):43-54. (Pubitemid 38117559)
52. Wong KK, Grunstein RR, Bartlett DJ, Gordon E. Brain function in obstructive sleep apnea: results from the Brain Resource International Database. J Integr Neurosci. 2006;5(1):111-121.
53. Bédard MA, Montplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol.1993;15(2):330-341. (Pubitemid 23156216)
54. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep. 1987;10(3):254-262.
55. Sforza E, Haba-Rubio J, De Bilbao F, et al. Performance vigilance task and sleepiness in patients with sleep-disordered breathing. Eur Respir J. 2004;24(2):279-285. (Pubitemid 39139797)
56. Findley L, Unverzagt M, Guchu R, Fabrizio M, Buckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest. 1995;108(3):619-624.
57. Findley LJ, Levinson MP, Bonnie RJ. Driving performance and automobile accidents in patients with sleep apnea. Clin Chest Med. 1992;13(3):427-435.
58. Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med. 2006;2(4):461-471. (Pubitemid 44763809)
59. Davies CW, Crosby JH, Mullins RL, et al. Case control study of cerebrovascular damage defined by magnetic resonance imaging in patients with OSA and normal matched control subjects. Sleep. 2001;24(6):715-720. (Pubitemid 32825509)
60. O'Donoghue FJ, Briellmann RS, Rochford PD, et al. Cerebral structural changes in severe obstructive sleep apnea. Am J Respir Crit Care Med. 2005;171(10):1185-1190. (Pubitemid 40663733)
61. Gale SD, Hopkins RO. Effects of hypoxia on the brain: neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J Int Neuropsychol Soc. 2004;10(1):60-71. (Pubitemid 38128463)
62. Macey PM, Henderson LA, Macey KE, et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;166(10):1382-1387. (Pubitemid 35292706)
63. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, Corfield DR. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4(5):451-454. (Pubitemid 37193029)
64. Fung SJ, Xi MC, Zhang JH, et al. Apnea promotes glutamate-induced excitotoxicity in hippocampal neurons. Brain Res.2007;1179: 42-50. (Pubitemid 47633508)
65. Xie H, Leung KL, Chen L, et al. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticity. Neurobiol Dis. 2010;40(1):155-162.
66. Ayalon L, Ancoli-Israel S, Aka AA, McKenna BS, Drummond SP. Relationship between obstructive sleep apnea severity and brain activation during a sustained attention task. Sleep. 2009; 32(3):373-381.
67. Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med.2011;183(10):1419-1426.
68. Halbower AC, Degaonkar M, Barker PB, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med. 2006;3(8):e301.
69. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev. 2003;7(1):35-51. (Pubitemid 36188305)
70. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004;27(1):123-128. (Pubitemid 43906323)
71. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165(7):934-939. (Pubitemid 34774660)
72. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3):348-353. (Pubitemid 38134813)
73. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-2171. (Pubitemid 32051681)
74. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003; 79(930):195-199.
75. Cohen MV. Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials? Ann Intern Med. 1989;111(11):918-931. (Pubitemid 20000027)
76. Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Spruyt K. Neurocognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics. 2010;126(5):e1161-e1167.
77. Ferini-Strambi L, Baietto C, Di Gioia MR, et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull. 2003;61(1):87-92. (Pubitemid 36682986)
78. Roth T, Rippon GA, Arora S. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Sleep Breath. 2008;12(1):53-62.
79. Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med. 2007;101(3):616-627. (Pubitemid 46196315)
80. Cooke JR, Ayalon L, Palmer BW, et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009;5(4) : 305-309.
81. Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc. 2004; 10(5):772-785. (Pubitemid 39264101)